Inventor · disambiguated record
Lars Kyhn Rasmussen
Also filed as: RASMUSSEN LARS KYHN
43 granted patents·9 pending applications·165 citations·filing 2010–2020
97Inventor score
Files withH LUNDBECK AS43MINDIMMUNE THERAPEUTICS INC3LUNDBECK & CO AS H2JORGENSEN MORTEN1KHANZHIN NIKOLAY1
Top patents by PatentIndex Score
52 records- 0197US11026923B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·17 claims
- 0297US11026924B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·19 claims
- 0396US10351561B2Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 16, 2019·12 cites·21 claims
- 0495US10806718B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Oct 20, 2020·7 cites·16 claims
- 0594US10034861B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 31, 2018·13 cites·28 claims
- 0693US11491140B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Nov 8, 2022·2 cites·20 claims
- 0793US10689379B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Jun 23, 2020·6 cites·14 claims
- 0893US10618913B2Macrocycles as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Apr 14, 2020·7 cites·19 claims
- 0993US10512632B21 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 24, 2019·9 cites·13 claims
- 1091US10766893B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Sep 8, 2020·6 cites·19 claims
- 1191US10011606B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 3, 2018·8 cites·24 claims
- 1291US9533992B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Jan 3, 2017·10 cites·9 claims
- 1388US10538525B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Jan 21, 2020·5 cites·15 claims
- 1488US9593105B2Cyclic aminesH LUNDBECK AS·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1587US10150771B2Triazolopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Dec 11, 2018·7 cites·8 claims
- 1687US9850249B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Dec 26, 2017·6 cites·5 claims
- 1786US10858362B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 8, 2020·2 cites·12 claims
- 1886US9415055B2Cyclic aminesH LUNDBECK AS·Filed 2015·Granted Aug 16, 2016·4 cites·18 claims
- 1986US9108938B2Cyclic aminesLUNDBECK & CO AS H·Filed 2013·Granted Aug 18, 2015·7 cites·24 claims
- 2085US11104680B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Aug 31, 2021·1 cites·15 claims
- 2185US10905688B2Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 2, 2021·2 cites·22 claims
- 2285US9643970B2Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2012·Granted May 9, 2017·8 cites·10 claims
- 2385US9434733B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2013·Granted Sep 6, 2016·7 cites·4 claims
- 2484US9102591B2BenzamidesLUNDBECK & CO AS H·Filed 2013·Granted Aug 11, 2015·6 cites·22 claims
- 2582US9993477B2Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jun 12, 2018·3 cites·6 claims
- 2680US9701665B2Quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2014·Granted Jul 11, 2017·3 cites·6 claims
- 2778US10633382B2Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Apr 28, 2020·2 cites·32 claims
- 2877US10912773B2Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 9, 2021·2 cites·22 claims
- 2977US9718832B2Hexahydrofuropyrroles as PDE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 1, 2017·2 cites·16 claims
- 3076US9861639B2Cyclic aminesH LUNDBECK AS·Filed 2017·Granted Jan 9, 2018·1 cites·22 claims
- 3173US2020375950A11h-pyrazolo[4,3-b]pyridines as pde1 inhibitorsH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 3272US11535611B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 27, 2022·1 cites·9 claims
- 3371US9649308B2Benzamide-containing compounds and their use in the treatment of painH LUNDBECK AS·Filed 2015·Granted May 16, 2017·1 cites·23 claims
- 3470US11472810B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Oct 18, 2022·0 cites·18 claims
- 3570US10005764B2Halogenated quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Jun 26, 2018·1 cites·15 claims
- 3666US8207347B2Pyridone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2010·Granted Jun 26, 2012·1 cites·20 claims
- 3758US10124010B2Cyclic aminesMIND IMMUNE THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·0 cites·20 claims
- 3858US2019307766A1Cyclic aminesMINDIMMUNE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3955US2020054630A1Benzamides-containing compounds and their use in the treatment of depressionMINDIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4054US2016318939A1Imidazopyrazinones as PDE1 InhibitorsH LUNDBECK AS·Filed 2016·Application pending·0 cites
- 4153US10526319B2Halogenated quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Jan 7, 2020·0 cites·19 claims
- 4253US2017291901A11,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 InhibitorsH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 4351US11634416B2Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridinesH LUNDBECK AS·Filed 2018·Granted Apr 25, 2023·0 cites·15 claims
- 4451US10238654B2Benzamides-containing compounds and their use in the treatment of epilepsyMINDIMMUNE THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·0 cites·18 claims
- 4550US10030007B2Quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 24, 2018·0 cites·11 claims
- 4648US10703751B2Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
- 4747US2022204489A1ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kv3 POTASSIUM CHANNEL ACTIVATORSH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 4846US11851425B2Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridinesH LUNDBECK AS·Filed 2018·Granted Dec 26, 2023·0 cites·15 claims
- 4945US2022220095A1N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERSH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 5042US2020131156A1ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORSH LUNDBECK AS·Filed 2019·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lars Kyhn Rasmussen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →